GRAIL, Inc. (GRAL) — Stock Score Summary

GRAIL, Inc. (GRAL) has a MoatMap StockRank of 17/100 based on Quality (40/100), Value (42/100), and Momentum (19/100) factor scores. The current signal is STRONG SELL. GRAIL is a high-burn, pre-profit healthcare company that fails our Terry Smith and Buffett lenses due to a lack of positive owner earnings and high commercialization uncertainty.

GRAIL, Inc. is a healthcare company dedicated to early cancer detection through its groundbreaking multi-cancer early detection (MCED) blood test, Galleri. Its proprietary sequencing technology, extensive clinical data, and sophisticated AI algorithms create a strong competitive moat in the rapidly emerging field of precision oncology. GRAIL aims to transform cancer care by enabling earlier intervention and improving patient outcomes.

Key Financial Metrics

Price$61.03
Market Cap$3.2B
P/E (Forward)-6.85
Price/Book1.09
Return on Equity-16.1%
Return on Invested Capital-18.8%
Debt/Equity2.04
Gross Margin49.3%
Operating Margin-332.9%
Revenue Growth28.1%
Free Cash Flow$-108M

GRAIL, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is GRAIL, Inc.’s (GRAL) StockRank?
MoatMap’s StockRank for GRAIL, Inc. (GRAL) is 17/100, with a Strong Sell signal. It is a composite of Quality (40), Value (42), and Momentum (19) factor ranks across MoatMap’s 19,000+ stock universe.
Does GRAIL, Inc. have an economic moat?
GRAIL, Inc. (GRAL) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is GRAIL, Inc. a buy, hold, or sell?
MoatMap’s current signal for GRAIL, Inc. (GRAL) is Strong Sell, based on a StockRank of 17/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is GRAIL, Inc. in?
GRAIL, Inc. (GRAL) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksGRAL deep dive reportAI ChampionsHow we score stocksSense-check another stock